About Robert Beyer
Form D filings for NoSortMeds from 2022 to 2023 list Robert Beyer as CEO & Director.
Robert Beyer first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Beyer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Beyer works with at each company, as listed on that company's latest Form D.
NoSortMeds, Inc. · Form D/A, Jul 18, 2023